Reduced exposure to calcineurin inhibitors in renal transplantation.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  New England Journal of Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 18536099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized Study Comparing Cyclosporine With Azathioprine One Year After Renal Transplantation–15-Year Outcome Data

  2007cited by this paper
• Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy.

  2003cited by this paper

• Exposure-response relationship of mycophenolic acid in pediatric lupus nephritis patients receiving multi-target therapy: An observational cohort study.

  2025cites this paper
• Renal function at 12 months of kidney transplantation comparing tacrolimus and mycophenolate with tacrolimus and mTORi in donors with different KDPI ranges. A multicenter cohort study using propensity scoring

  2023cites this paper
• Kidney Transplantation Long-Term Management Challenges Long-Term Immunosuppression Management Opportunities and Uncertainties

  2021cites this paper
• New Approaches to Cardiovascular Disease and Its Management in Kidney Transplant Recipients

  2021cites this paper
• Analyzing the clinical outcomes of switching from cyclosporine to tacrolimus in pediatric hematopoietic stem cell transplantation

  2021cites this paper
• BK Polyomavirus Nephropathy in Kidney Transplantation: Balancing Rejection and Infection

  2021cites this paper
• Pretransplant Calculated Panel Reactive Antibody in the Absence of Donor-Specific Antibody and Kidney Allograft Survival.

  2021cites this paper
• Effect of Tacrolimus Metabolism Rate on Renal Func-tion Among Hispanic Kidney Transplant Recipients

  2020influential citation
• Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study.

  2020cites this paper
• Chronická dysfunkce transplantované ledviny: stále nevyřešený problém

  2020cites this paper
• Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus

  2019cites this paper
• Prospective nonrandomized study with early steroid withdrawal (Day 5) postrenal transplant in low immunological risk patients: A singlecenter experience at prince sultan military medical city Riyadh

  2019cites this paper
• Impact of Increased Duration of Trimethoprim-Sulfamethoxazole Prophylaxis for Pneumocystis Pneumonia After Renal Transplant

  2019cites this paper
• Induction Therapy in Half-Haplotype Low Risk Kidney Transplant Patients: Impact on Acute Rejection, Graft Survival, Infection and Surgical Complications at 3 Years

  2019cites this paper
• High Calcineurin Inhibitor Intrapatient Variability Is Associated With Renal Allograft Inflammation, Chronicity, and Graft Loss

  2019cites this paper
• Long-term clinical impact of adaptation of initial tacrolimus dosing to CYP 3 A 5 genotype

  2019cites this paper
• Enfermedad coronaria en el trasplante renal: incidencia, tipología, factores de riesgo y pronóstico

  2019influential citation
• Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.

  2018cites this paper
• Immunological Challenges in Kidney Transplantation

  2018cites this paper
• Colitis eosinofílica secundaria a tacrolimus en un paciente pediátrico trasplantado renal. Reporte de caso

  2018cites this paper
• Establishing a Core Outcome Measure for Graft Health: A Standardized Outcomes in Nephrology-Kidney Transplantation (SONG-Tx) Consensus Workshop Report

  2018cites this paper
• [Focusing on kidney transplantation in the elderly].

  2018cites this paper
• Calcineurin inhibitor-induced endothelial cell injury – A role for complement

  2018influential citation
• Understanding Medication Nonadherence after Kidney Transplant.

  2017cites this paper
• Syddansk Universitet The Pharmacogenetics of Tacrolimus in Corticosteroid-Sparse Pediatric and Adult Kidney Transplant Recipients

  2017cites this paper
• Therapeutic monitoring of the immuno-modulating drugs in systemic lupus erythematosus

  2017cites this paper
• Tac-MMF Versus CsA-MMF/CsA-AZA-Based Regimens in Development of De Novo Complement-Binding Anti-HLA Antibodies After Kidney Transplantation.

  2017cites this paper
• Critical analysis of graft loss and death in kidney transplant recipients treated with mTOR inhibitors.

  2017cites this paper
• Biologics in Transplantation (Anti-thymocyte Globulin, Belatacept, Alemtuzumab): How Should We Use Them?

  2017cites this paper
• Polyomavirus Reactivation and Immune Responses to Kidney-Specific Self-Antigens in Transplantation.

  2017cites this paper
• The effect of the applied induction immunosuppressive therapy protocol on the allografted kidney condition

  2017cites this paper
• The current burden of cytomegalovirus infection in kidney transplant recipients receiving no pharmacological prophylaxis.

  2017influential citation
• In human cell cultures, everolimus is inferior to tacrolimus in inhibiting cellular alloimmunity, but equally effective as regards humoral alloimmunity

  2017cites this paper
• Conversion to mammalian target of rapamycin inhibitors in kidney transplant recipients with de novo cancers

  2017cites this paper
• Influence of tacrolimus metabolism rate on renal function after solid organ transplantation

  2017cites this paper
• Renal Transplantation : An Update for Anaesthetists

  2017cites this paper
• Drug-drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitus.

  2017cites this paper
• Immunosuppressant prescription pattern and trend in kidney transplantation: A multicenter study in Korea

  2017cites this paper
• Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation

  2017cites this paper
• Toward Establishing Core Outcome Domains For Trials in Kidney Transplantation: Report of the Standardized Outcomes in Nephrology—Kidney Transplantation Consensus Workshops

  2017cites this paper
• Rascher Steroidentzug nach Nierentransplantation

  2017cites this paper
• Title Conversion to mammalian target of rapamycin inhibitors inkidney transplant recipients with de novo cancers

  2017cites this paper
• Understanding Trends in Kidney Function 1 Year after Kidney Transplant in the United States.

  2017cites this paper
• Current Approaches for Marginal Donor Usage in Kidney Transplantation

  2016cites this paper
• Title Involvement of autophagy in the pharmacological effects of themTOR inhibitor everolimus in acute kidney injury

  2016cites this paper
• A Case of Pregnancy following Allogeneic Uterine Transplantation in a Rabbit Model Pregnancy following allogeneic rabbit UTn

  2016cites this paper
• Tacrolimus Toxicity With Minimal Clinical Manifestations: A Case Report and Literature Review

  2016cites this paper
• Calcineurin Inhibitor-Sparing Strategies in Renal Transplantation: Where Are We? A Comprehensive Review of the Current Evidence.

  2016cites this paper
• Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti‐IL2 Receptor Monoclonal Antibodies?

  2016cites this paper
• Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants

  2016cites this paper
• Reporting Quality-of-Life Outcomes in Clinical Trials of Immunosuppressive Therapy in Kidney Transplantation.

  2016cites this paper
• Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients

  2016cites this paper
• Risk assessment and management of post-transplant diabetes mellitus.

  2016cites this paper
• Análisis de la supervivencia a 10 años de trasplante renal en el Hospital de Alta Especialidad de Veracruz

  2016cites this paper
• The impact of slow graft function on graft outcome is comparable to delayed graft function in deceased donor kidney transplantation

  2016cites this paper
• Examining a role for histone deacetylase inhibitors asimmunosuppressants in organ transplantation

  2016cites this paper
• Immunosuppression: Induction, Maintenance, and Steroid Avoidance Protocols

  2016influential citation
• Where the Sun Shines: Industry's Payments to Transplant Surgeons

  2016cites this paper
• [Chronic dysfunction of a transplanted kidney: the problem still unresolved].

  2016cites this paper
• Impact of mTOR Inhibitors on Cancer Development in Kidney Transplantation Recipients: A Population-Based Study.

  2016cites this paper
• Belatacept and Long-Term Outcomes in Kidney Transplantation.

  2016cites this paper
• Strategies to optimize tacrolimus treatment and improve long-term clinical outcomes in solid organ transplantation

  2016influential citation
• Renal transplantation in adults

  2016cites this paper
• Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future?

  2016cites this paper
• Relationships of Selected CYP and ABCB1 Single Nucleotide Polymorphisms and Patient Characteristics with the Pharmacokinetics of Twice Daily Tacrolimus and Advagraf® in Renal Transplant Recipients

  2016cites this paper
• Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.

  2016cites this paper
• Multivariable risk of developing new onset diabetes after transplant—results from a single‐center study of 481 adult, primary kidney transplant recipients

  2015cites this paper
• Through a glass darkly: seeking clarity in preventing late kidney transplant failure.

  2015cites this paper
• Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I.

  2015cites this paper
• Post-transplantation malignancies: here today, gone tomorrow?

  2015cites this paper
• Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.

  2015cites this paper
• Influence of Sex and Race on Mycophenolic Acid Pharmacokinetics in Stable African American and Caucasian Renal Transplant Recipients

  2015cites this paper
• Generation of mycophenolate mofetil resistant lymphocytes for adoptive immunotherapy

  2015cites this paper
• Mycophenolate mofetil for lupus nephritis: an update

  2015cites this paper
• One year follow-up of the cardio-metabolic profile evolution in renal transplant patients treated with alemtuzumab, cyclosporine, and steroids in a reference hospital in Colombia

  2015influential citation
• Conversión tardía desde un régimen basado en inhibidores de calcineurina a everolimus en receptores de trasplante renal. Seguimiento a 24 meses.

  2015cites this paper
• Evolución del peso, densidad mineral ósea y metabolismo lipídico en el paciente trasplantado renal.

  2015cites this paper
• Exposure to Mycophenolic Acid Better Predicts Immunosuppressive Efficacy Than Exposure to Calcineurin Inhibitors in Renal Transplant Patients

  2014cites this paper
• Preliminary Report of Major Surgery in Liver Transplant Recipients Receiving m-TOR Inhibitors without Therapeutic Discontinuation

  2014cites this paper
• Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up

  2014cites this paper
• Tacrolimus therapeutic drug monitoring and pediatric renal transplant graft outcomes

  2014cites this paper
• Analysis of 1,500 Kidney Transplantations at Sungkyunkwan University

  2014cites this paper
• Identifying risk factors for delayed graft function, acute rejection and subclinical acute rejection in renal transplant recipients on controlled cyclosporine exposure

  2014cites this paper
• Adenosine triphosphate production by peripheral blood CD4⁺T cells in clinically stable renal transplant recipients.

  2014influential citation
• The Cost of Kidney Transplant over Time

  2014cites this paper
• Stable immunosuppression under low-dose Tacrolimus monotherapy is dependent upon immunological regulation

  2014cites this paper
• Erratum to: New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin®) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity

  2014cites this paper
• Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction : REFERENCE Study 3-Year Follow Up

  2014cites this paper
• Chronic Allograft Nephropathy (Chronic Allograft Damage): Can It Be Avoided?

  2014cites this paper
• Clinical evaluation of the QMS® Tacrolimus immunoassay.

  2014cites this paper
• Alemtuzumab induction therapy in kidney transplantation.

  2014cites this paper
• Co-stimulatory blockade with belatacept in kidney transplantation

  2014cites this paper
• Actual 10-year Outcomes of Tacrolimus/MMF Compared with Cyclosporin/MMF in Kidney Transplantation

  2014cites this paper
• mTOR inhibitors and renal allograft: Yin and Yang

  2014cites this paper
• Belatacept in kidney transplantation

  2014cites this paper
• Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients.

  2013cites this paper
• TGF-β1 Expression in Kidney Allograft Protocol Biopsies during Cyclosporine: a Therapy

  2013cites this paper
• Optimising the use of mTOR inhibitors in renal transplantation

  2013cites this paper
• Corticosteroid and calcineurin inhibitor sparing regimens in kidney transplantation.

  2013cites this paper
• JAK3 inhibition: what potential for the future?

  2013cites this paper